Literature DB >> 2968825

In vivo platelet activity and serum albumin concentration in nephrotic syndrome.

F Goubran1, F Maklady.   

Abstract

To clarify the relationship between serum albumin concentration and in vivo platelet activity in nephrotic syndrome, Beta-thromboglobulin (B-TG) levels and circulating platelet aggregation ratio (PAR) were determined in 25 nephrotic patients. PAR levels were significantly decreased compared with the controls and showed a positive correlation with serum albumin concentrations. The values of B-TG were high in all nephrotic patients and showed an inverse relationship with serum albumin levels. In addition, increased B-TG levels correlated with decreased PAR values. Therefore serum albumin plays a regulatory role in the activity of circulating platelets in the nephrotic syndrome. Prospective longitudinal studies must be done to elucidate the usefulness of platelet inhibitors as a prophylactic therapy of intravascular thrombosis in nephrotic patients.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2968825     DOI: 10.1007/bf00320629

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  14 in total

1.  Arachidonic acid metabolites and the interactions between platelets and blood-vessel walls.

Authors:  S Moncada; J R Vane
Journal:  N Engl J Med       Date:  1979-05-17       Impact factor: 91.245

2.  Platelet hyperaggregability and the nephrotic syndrome.

Authors:  G Remuzzi; G Mecca; D Marchesi; M Livio; G de Gaetano; M B Donati; M J Silver
Journal:  Thromb Res       Date:  1979       Impact factor: 3.944

3.  Nephrotic syndrome. A hypercoagulable state.

Authors:  A G Kendall; R C Lohmann; J B Dossetor
Journal:  Arch Intern Med       Date:  1971-06

4.  Circulating platelet aggregates in ischaemic heart disease and their correlation to platelet life span.

Authors:  H H Salem; J Koutts; B G Firkin
Journal:  Thromb Res       Date:  1980-03-01       Impact factor: 3.944

5.  Increased platelet aggregates in patients with transient ischemic attacks.

Authors:  K K Wu; J C Hoak
Journal:  Stroke       Date:  1975 Sep-Oct       Impact factor: 7.914

6.  The metabolism of arachidonic acid by platelets in nephrotic syndrome.

Authors:  A Schieppati; P Dodesini; A Benigni; M Massazza; G Mecca; G Remuzzi; M Livio; G de Gaetano; E C Rossi
Journal:  Kidney Int       Date:  1984-04       Impact factor: 10.612

7.  Release of arachidonic acid from human platelets. A key role for the potentiation of platelet aggregability in normal subjects as well as in those with nephrotic syndrome.

Authors:  N Yoshida; N Aoki
Journal:  Blood       Date:  1978-11       Impact factor: 22.113

8.  Platelet aggregation and beta-thromboglobulin levels in nephrotic patients with and without thrombosis.

Authors:  U Kuhlmann; J Steurer; K Rhyner; A von Felten; J Briner; W Siegenthaler
Journal:  Clin Nephrol       Date:  1981-05       Impact factor: 0.975

9.  The influence of albumin and calcium on human platelet arachidonic acid metabolism.

Authors:  M J Stuart; J M Gerrard; J G White
Journal:  Blood       Date:  1980-03       Impact factor: 22.113

10.  Relationship between platelet aggregation, thromboxane synthesis and albumin concentration in nephrotic syndrome.

Authors:  C A Jackson; M Greaves; A D Patterson; C B Brown; F E Preston
Journal:  Br J Haematol       Date:  1982-09       Impact factor: 6.998

View more
  2 in total

1.  Platelet-derived growth factor and platelet profiles in childhood nephrotic syndrome.

Authors:  Anna M Wasilewska; Walentyna M Zoch-Zwierz; Barbara Tomaszewska; Anna Biernacka
Journal:  Pediatr Nephrol       Date:  2004-10-13       Impact factor: 3.714

Review 2.  Platelet abnormalities in nephrotic syndrome.

Authors:  Benedicte Eneman; Elena Levtchenko; Bert van den Heuvel; Chris Van Geet; Kathleen Freson
Journal:  Pediatr Nephrol       Date:  2015-08-13       Impact factor: 3.714

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.